INDOUS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Indo Us Bio-Tech Ltd

Watchlist Manager

Watchlist

Price: 73.54 INR -6.15%

Market Cap: ₹1.5B

	Indo Us Bio-Tech Ltd NSE:INDOUS	IN
L	Lloyds Banking Group PLC F:LLD2	UK
	Proto Labs Inc NYSE:PRLB	US
	Real Matters Inc F:R3E	CA
N	Norditek Group AB F:O5D	SE
A	Automatic Data Processing Inc DUS:ADP	US

Profitability Summary

Indo Us Bio-Tech Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

25%

Sustainable 3Y Average Gross Margin

30%

Declining Gross Margin

29% > 25%

Healthy Operating Margin

13%

Sustainable 3Y Average Operating Margin

15%

Declining Operating Margin

14% > 13%

Healthy Net Margin

10%

Sustainable 3Y Average Net Margin

13%

Declining Net Margin

12% > 10%

Negative Free Cash Flow Margin

-13%

Negative 3Y Average Free Cash Flow Margin

-5%

Declining Free Cash Flow Margin

0% > -13%

Positive ROE

13%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

Declining ROIC

14% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.